insights_auto
Why is OCEA down 37.50%?
Dive Deeperchevron_right
OCEA:OTCMKTS
Ocean Biomedical Inc
$0.00050
arrow_downward
-37.50%(-0.00030) 1D
Oct 14, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OCEA...
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
80.17K
Avg. vol.
39.96K
Volume
349.75K
52-wk high
$0.01
52-wk low
$0.00
Beta
2.65
Shares outstanding
232.36M
No. of employees
7
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
80.17K
Avg. vol.
39.96K
Volume
349.75K
52-wk high
$0.01
52-wk low
$0.00
Beta
2.65
Shares outstanding
232.36M
No. of employees
7
News stories
From web sources and news partners
marketscreener.com
·
36 minutes ago
Coreweave unravels
Reuters
·
52 minutes ago
S&P 500's march to 8,000 hinges on 'very, very strong' third quarter
The Motley Fool
·
20 minutes ago
History Says Berkshire Hathaway Stock Holds Up When the Market Falls: It Beat the S&P 500 in 11 of 13 Down Years
Profile
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
About Ocean Biomedical Inc